Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Finished Goods (2019 - 2025)

Outset Medical (OM) has disclosed Finished Goods for 7 consecutive years, with $13.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Finished Goods fell 44.71% to $13.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.1 million, a 44.71% decrease, with the full-year FY2025 number at $13.1 million, down 44.71% from a year prior.
  • Finished Goods was $13.1 million for Q4 2025 at Outset Medical, down from $15.8 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $26.4 million in Q2 2024 to a low of $6.1 million in Q1 2021.
  • A 5-year average of $17.8 million and a median of $17.6 million in 2022 define the central range for Finished Goods.
  • Peak YoY movement for Finished Goods: soared 300.0% in 2021, then plummeted 46.17% in 2023.
  • Outset Medical's Finished Goods stood at $15.0 million in 2021, then soared by 44.95% to $21.8 million in 2022, then grew by 0.06% to $21.8 million in 2023, then increased by 8.86% to $23.7 million in 2024, then crashed by 44.71% to $13.1 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Finished Goods are $13.1 million (Q4 2025), $15.8 million (Q3 2025), and $17.8 million (Q2 2025).